News

i1-574837-1408668177300.jpg

With greater attention and acceptance of biomarker use in clinical trials, the Society of Nuclear Medicine (SNM) is hoping to capitalize on its expertise in this area through the creation of the SNM Clinical Trials Network.

i1-574838-1408668173260.jpg

A look into the current state of the eCTD format as well as its future in industry from a global standpoint.

i1-574839-1408668169286.jpg

Pathways to Patients

Regional recruitment managers are on the rise, providing a unique approach to onsite subject enrollment.

Good Products, a provider of Enterprise Content Management (ECM) solutions and Clinical Technology Consulting for the pharmaceutical, biotechnology and medical device industries, today announced a major expansion to new UK headquarters in Nottingham, UK.

Entelos, Inc. today announced that it has entered into an agreement with the U.S. Food and Drug Administration (FDA) to use the Entelos Cardiovascular PhysioLab to assess the cardiovascular safety and efficacy of a specific drug class and a set of drugs within that class.

PPD, Inc. and IDA Ireland (Investment and Development Agency) today announced that PPD plans to expand its contract research operations into Athlone, Ireland, by initially establishing a cGMP analytical testing laboratory to meet growing client demand in Europe, Middle East and Africa (EMEA) for these services.

DIA has rescheduled its 3rd Annual Conference on Drug Discovery and Clinical Development in India, which was recently postponed due to recent violence in the area.

Preparing for a busy year ahead, the European Medicines Agency's Management Board adopted the Agency's work program and draft budget for 2009 at its meeting on December 11, 2008.

ICON Medical Imaging has launched a new cardiac echocardiography analysis software which attempts to address important unmet needs in clinical trials using echocardiography.

Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry has announced the opening of its new U.S. headquarters and analytical lab facilities in the vicinity of Research Triangle Park, North Carolina.

PAREXEL International Corporation, a global biopharmaceutical services provider, announced today that it has established an alliance with Safe Implementation of Treatments in Stroke (SITS) International, a worldwide network of clinical sites with specialized capabilities in the area of stroke.

Bio-Imaging Technologies, Inc., a healthcare contract service organization, today announced it has partnered with AG Mednet, a global diagnostic imaging network, to provide a complete imaging service for clinical trials.

Drug Safety Alliance (DSA) offered details at the recent Seventh Annual International Users Conference in San Francisco, CA on how a well-designed signal management program and select tools can help pharmaceutical companies with early detection of new safety information.

Clinical Trials & Surveys Corp. (C-TASC), a clinical trials solutions company, announced today that it has been selected to provide data management software and services to New York University School of Medicine (NYU), one of eight sites collecting data for a study being conducted by the Early Detection Research Network.